Skip to main content
. 2024 Nov 13;29(22):5341. doi: 10.3390/molecules29225341

Scheme 6.

Scheme 6

Synthesis (A) and anticancer evaluation (B) of thiazolidine-2,4-dione hybrids developed by Eissa’s group. (HepG2: hepatic carcinoma cells; HCT-116, HT-29 and Caco-2: colon cancer cells; MCF-7 and MDA-MB-231: breast cancer cells; A549: lung cancer cells; VERO: normal kidney cells; Sor: sorafenib; Dox: doxorubicin).